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A psychoeducation tool for patients with first-episode psychosis
Psychoeducation and schizophrenia
Psychoeducation interventions have been
developed to explain illness and treatment
to people with schizophrenia, in order to
enable them to cope more effectively with
their illness. Psychoeducational
interventions are administrated in group,
individual, family or multifamily group
formats and address the illness from a
multidimensional viewpoint, including
biological, psychological and social
perspectives. Participants are usually
provided with information, emotional
support and management strategies. Most
often the intervention includes didactic
materials such as leaflets, flyers,
presentation slides, posters, movies and so
on. In terms of efficacy, psychoeducational
interventions seem to reduce the risk of
relapse rate, hospital readmission and
length of stay and promote medication
compliance (1). It has been pinpointed that
the optimal time for starting
psychoeducation is still unknown, but it is
suggested that psychoeducation should be
offered as early as possible in order to be
more effective (2). However, few studies
have validly assessed the best timing for
psychoeducation. Feldman et al. (2) found
that psychoeducation in patients with
either long (>7 years) or short (<5 years)
illness duration did not influence 5-year
rate of readmission, while it did so in
those whose illness duration ranged from
5 to 7 years. The authors hypothesised
that in participants with longer duration of
illness, psychoeducation may actually
reinforce a more fatalistic view of the
illness, while it may fail to have any
impact on participants with shorter
duration of illness due to illness denial.
This suggests that insight may play a more
central role in this issue; in our
experience, psychoeducation in itself may
actually promote insight in the early phase
of psychosis, provided content is properly
adapted. However, most psychoeducational
interventions are designed for patients
suffering from well-established
schizophrenia and their content may be
inappropriate for first-episode psychosis
(FEP) patients. There is therefore a need
for new tools to address this issue in this
patient population.
Psychoeducation in FEP patients
To our knowledge, most published
psychoeducational interventions for people
with FEP include families (3,4) or focus
on specific topics such as cannabis
use (5). Psychoeducational interventions
with FEP patients face several important
challenges. First, FEP patients’ viewpoint
about their psychotic experience and their
perception of the relevance is that the
information they receive has been very
little studied. The initial psychotic episode
is often described as a confusing and
frightening experience; it is accompanied
by feelings of losing control and
strangeness. Although the given
information can be perceived as pertinent
and meaningful if it is congruent with the
experience of psychosis, it can also feel
unacceptable or confusing if the words
used are too specialised or technical, if
clinicians do not base psychoeducation
material on patients’ experience or if
provided information is too pessimistic or
life-limiting. Patients may then reject such
information in order to protect their
self-esteem. Hence, psychoeducation
interventions are likely to be accepted if
the patients can integrate the given
information in a way that allows them to
cope better with their experience. Second,
early intervention strategies are based on
the postulate that the outcome in this phase
of psychosis can be influenced by various
interventions, which is more unlikely later
in the evolution of the disorder. Although
it may be premature to draw definitive
conclusions about the actual impact of
these new interventions and to integrate
such results in psychoeducational
programmes, elements on these new ways
to approach treatment should nevertheless
be presented to patients. For example, data
from a large Early Psychosis Prevention
and Intervention Centre study indicate that
likelihood of symptom remission was
significantly higher in patients who
decreased or ceased substance use
compared to those who continued to abuse
substances. In addition, patients who
reduced use appeared to have even better
outcomes at 18 months than those who
had never used substances (6). It is likely
that such data may have an impact on
patients if included in psychoeducational
material, but it is often difficult to convey
such information in an accessible way.
Third, patients who develop an FEP
belong to a generation that has been the
market target of numerous commercial
firms during their adolescence. They are
therefore used for good marketing
techniques and will probably be more
critical towards any new product,
including psychoeducational tools.
Additionally, this generation is used to
channel-flick when a programme does not
suit them. In this context,
psychoeducational tools should provide
concise and hard-hitting messages with
attractive material. New interventions with
patients suffering from well-established
schizophrenia try to take care of these
marketing aspects in making programmes
attractive and entertaining (7,8). A
psychoeducation programme for FEP
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patients should also meet these different
challenges.
A psychoeducation tool for patients
with FEP
In this article, we present a four sessions’
psychoeducational programme used in a
hospital unit specialised in the acute
treatment of FEP patients. The programme
is currently composed of four modules:
(a) psychotic symptoms, (b) cannabis and
psychosis, (c) psychosis and medication
and (d) psychosis and recovery. Each
module includes a folder containing 9–11
cards. Each card contains a statement title
illustrating a theme considered important
for psychoeducation, a vignette related to
this theme and is illustrated by a cartoon.
Examples of cards are to be seen below:
Psychosis is not the end of the world
Suzanne just learned she has a
psychotic disorder. She reminisces about
‘One Flew over the Cuckoo’s Nest’ and
thinks she will end up like a vegetable.
She is terrified because not so long ago,
just before she became sick, she had a lot
of projects for her future.
The term ‘psychotic’ is a word that is
often been misconstrued from its original
meaning by the media. They use it in
every way to designate fear, erratic
behaviour, dangerousness or phenomena
that are beyond belief. Terms stemming
from psychiatry have often become part of
everyday vocabulary while losing their
medical meaning.
Its true that in the past, the treatment of
psychotic disorders included medication
that knocked the patients out or gave them
a rigid demeanour, along with
electroshock therapy or confinement.
Nowadays, the medications have become
much more specific and are prescribed in
small dosage. From a neurological
standpoint, they have very few to no side
effects. Electroshock therapy is very
seldom used and once the acute episode is
under control, the treatment is ambulatory.
The reduction of risk factors, the
monitoring of a preventive medication
treatment and the acquisition of
competences in disorder management
allow to reduce the risk of a relapse and to
actively work towards resuming life
projects. About 85% of the patients will
not experience psychotic symptoms after
6 months of treatment. One third of the
patients fully recover. We also know that
the chances of recovery increase if the
patients and their therapeutic team manage
to develop a cooperative relationship.
Its my soul that’s hurting, not my molecules!!
Martin is not feeling well, he hears
scary voices, he is sad and he has been
suffering for several weeks. Yet, when the
doctor suggests medication, he refuses and
says:
‘. . . I’m not feeling well, I’m sad, but
it’s not a chemical thing, it’s feelings. It’s
my soul that’s hurting, not my molecules!’
For quite a while, psychiatrists had a
hard time agreeing:
1 Some were saying that psychosis was
a psychological problem based on life’s
incidents, going through hardships and
that the way to solve the problem was
through psychotherapy.
2 Others were saying that psychosis is a
brain disease, a matter of biology and
that medication was the best way to deal
with it.
We now know that its actually a little
bit of both. The disease often manifests
itself in the context of trying events in
life, but biology also plays a part. The
overwhelming majority of caregivers agree
on the fact that the two kinds of
treatments must be combined: medication
and psychotherapy.
When dealing with psychosis, the
recovery of a person’s balance relies on
several pillars: the patient’s resources, the
support of caregivers, friends and relatives,
communication, psychotherapy and
medication. Once that balance has been
re-established, and the patients’ resources
are solid again, the other pillars can then
be gradually removed; the person gets out
of the hospital, they do not need as much
help from caregivers and medication can
be gradually decreased, if not terminated.
A good spliff is relaxing
The effects of cannabis vary not only
from one person to the next, depending on
the quantity used, but also on the context
of this use. Consumers look for the
relaxing or stimulating effects of
Tetrahydrocannabinol (THC). But they do
not always obtain these effects.
Dependence to the product decreases these
effects and increases the negative
consequences. Think of the effects of your
very first joints. How many do you need
now to have the same reaction?
Cannabis makes psychosis worse by
increasing strange voices and ideas. It
seriously decreases the ability to focus on
people suffering from this disorder and it
reduces their motivation. These adverse
effects increase social exclusion, which
causes significant stress to the user.
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Its not fair!
Marc was a successful senior in high
school who planned on going to college.
A few weeks before his final exams he
gradually started having a hard time
concentrating and felt a little threatened by
his classmates. The symptoms got worse.
He was hospitalised and could not take his
finals. Marc felt sad, belittled and that
what was happening to him was unfair.
He thought, ‘Why me’?
He was right, it was totally unfair, but
thanks to the work they did at the hospital
and the medication treatment, he
recovered from this episode. Thanks to the
therapy he continued to follow after being
hospitalised; Marc learned to better cope
with stress and to accept the vulnerability
that comes with psychosis. In the end, he
managed to graduate from high school.
Psychosis can have a negative effect on
self-esteem. Therapy can help a person
rebuild themselves and find the means to
regain control over their life. The
psychotic episode turned into an
opportunity to develop better knowledge
of self and to strengthen the aspects that
were exposed as being fragile.
How the programme is led
The intervention is directed to patients
who have recovered well enough from the
acute episode to attend a group meeting.
The sessions are held once a week for
45 min in a comfortable meeting room.
The intervention is led by a psychiatrist
and a nurse. Every session focuses on one
of the four themes: psychosis, medication,
cannabis and recovery. To begin the
meeting, the goal of the session is briefly
presented; new participants are welcomed
and introduced to the group. Then the
participants receive the folder containing
the various cards and have a few minutes
to go through the cards to choose one or
two of them. Alternately, each participant
reads the chosen cards. Then the leaders
will ask the participants why they have
chosen these specific cards in order to
launch the discussion; they facilitate the
discussion, make short summaries and
reformulations and provide additional
information on the basis of questions that
may occur. They may also ask other
participants to explain how they have
solved a problem or a question raised.
Clinical experience indicates that this
psychoeducational programme meets the
need of the participants and a study to
assess its efficacy in naturalistic hospital
conditions as well as in an outpatient
setting is planned. New cards are in
development, notably a folder on trauma
and psychosis which is identified as a
major problem with FEP patients (9) as
well as one on affective symptoms
associated with bipolar disorders (10).
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